Fact CheckerSign in

NCT05208086Active, not recruiting

Diagnostic Performance of Spot Urine Sample for the Monoclonal Components Detection in Patients With Multiple Myeloma

Diagnostic Performance of Spot Urine Sample for the Monoclonal Components Detection in Patients With Multiple Myeloma RHU(M)M Random or H24 Urine in (Multiple) Myeloma

Source: ClinicalTrials.gov · Last updated 13 Apr 2026

Brief summary (registry, in English)

The primary objective of the study is to evaluate at Day 1 Cycle 2, the detection sensitivity of the urinary monoclonal component on a spot urine sample, compared to the reference measurement on 24-hour urine, in patients with Multiple Myeloma.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
180 (estimated)
First submitted
16 Dec 2021
Start date
18 May 2022
Primary completion date
May 2026
Lead sponsor
Intergroupe Francophone du Myelome
NCT number
NCT05208086

What you commit to

  • Study type: Observational
  • Planned participants: 180
  • From 18 May 2022 to the primary completion date, May 2026
  • 18 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Person under guardianship, trusteeship or deprived of freedom by a judicial or administrative decision

Who the study is looking for

  • Patient with Multiple Myeloma
  • Patient starting new treatment line, whatever the line is, but with at least 3 induction cycles
  • Urine monoclonal component ≥ 200mg/24h

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (18)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ch Annecy Genevois
Coordinator of this site? Confirm its status
AnnecyFranceUnknown status
Centre Hospitalier Métropole de Savoie
Coordinator of this site? Confirm its status
ChambéryFranceUnknown status
Chu Francois Mitterand
Coordinator of this site? Confirm its status
DijonFranceUnknown status
CH de Dunkerque
Coordinator of this site? Confirm its status
DunkirkFranceUnknown status
CHD Vendée
Coordinator of this site? Confirm its status
La Roche-sur-YonFranceUnknown status
Hopital Bicetre
Coordinator of this site? Confirm its status
Le Kremlin-BicêtreFranceUnknown status
CH Le Mans
Coordinator of this site? Confirm its status
Le MansFranceUnknown status
CH de Lens
Coordinator of this site? Confirm its status
LensFranceUnknown status
Hopital Claude Huriez-CHRU LILLE
Coordinator of this site? Confirm its status
LilleFranceUnknown status
Centre Hospitalier Lyon Sud
Coordinator of this site? Confirm its status
LyonFranceUnknown status
CHU de Montpellier
Coordinator of this site? Confirm its status
MontpellierFranceUnknown status
Hôpital E. Muller
Coordinator of this site? Confirm its status
MulhouseFranceUnknown status
CHRU Nantes
Coordinator of this site? Confirm its status
NantesFranceUnknown status
CHU Pontchaillou
Coordinator of this site? Confirm its status
RennesFranceUnknown status
CHU Toulouse
Coordinator of this site? Confirm its status
ToulouseFranceUnknown status
CHRU Bretonneau
Coordinator of this site? Confirm its status
ToursFranceUnknown status
CH Bretagne Atlantique Vannes et Auray - P. Chubert
Coordinator of this site? Confirm its status
VannesFranceUnknown status
CH de Versailles
Coordinator of this site? Confirm its status
VersaillesFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.